Cargando…

The Future of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention: A Global Qualitative Consultation on Provider Perspectives on New Products and Differentiated Service Delivery

Differentiated service delivery and new products, such as long-acting injectable cabotegravir (CAB-LA) and the dapivirine vaginal ring (DVR), could increase uptake and use of pre-exposure prophylaxis (PrEP) for HIV prevention. We explored PrEP provider perspectives on differentiated PrEP service del...

Descripción completa

Detalles Bibliográficos
Autores principales: Henderson, Mary, Schmidt, Heather-Marie A, Chitembo, Lastone, Peralta, Hortencia, Alaama, Ahmed S, Johnson, Cheryl, Baggaley, Rachel, Schaefer, Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589125/
https://www.ncbi.nlm.nih.gov/pubmed/37351685
http://dx.doi.org/10.1007/s10461-023-04093-1
_version_ 1785123721182183424
author Henderson, Mary
Schmidt, Heather-Marie A
Chitembo, Lastone
Peralta, Hortencia
Alaama, Ahmed S
Johnson, Cheryl
Baggaley, Rachel
Schaefer, Robin
author_facet Henderson, Mary
Schmidt, Heather-Marie A
Chitembo, Lastone
Peralta, Hortencia
Alaama, Ahmed S
Johnson, Cheryl
Baggaley, Rachel
Schaefer, Robin
author_sort Henderson, Mary
collection PubMed
description Differentiated service delivery and new products, such as long-acting injectable cabotegravir (CAB-LA) and the dapivirine vaginal ring (DVR), could increase uptake and use of pre-exposure prophylaxis (PrEP) for HIV prevention. We explored PrEP provider perspectives on differentiated PrEP service delivery and new PrEP products to inform World Health Organization (WHO) guidelines and programme implementation. 150 PrEP providers who participated in a WHO survey were randomly selected and 67 were invited for interviews based on geographic representation, provider cadre, gender, experience with community-based PrEP service delivery, and familiarity with new PrEP products. Semi-structured interviews were conducted virtually. Key themes were inductively extracted relating to differentiated service delivery and benefits and concerns regarding new PrEP products. 30 PrEP providers from 24 countries were interviewed. Across regions, providers were supportive of differentiated service delivery to respond to clients’ needs and preferences, maintain services during COVID-19, and ensure access for priority populations that may face access challenges. Providers welcomed prospects of offering CAB-LA to their clients but had concerns about HIV testing, costs, and the need for clinic-based services, including staff who can administer injections. Providers felt the DVR was potentially important for some cisgender women, especially young clients and female sex workers, and raised fewer concerns compared to injectable PrEP. Providers’ views are critical for the development of guidelines and implementing programmes that will best serve PrEP users. Understanding areas where provider capacities and biases may create barriers can define opportunities for training and support to ensure that providers can deliver effective programmes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10461-023-04093-1.
format Online
Article
Text
id pubmed-10589125
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-105891252023-10-22 The Future of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention: A Global Qualitative Consultation on Provider Perspectives on New Products and Differentiated Service Delivery Henderson, Mary Schmidt, Heather-Marie A Chitembo, Lastone Peralta, Hortencia Alaama, Ahmed S Johnson, Cheryl Baggaley, Rachel Schaefer, Robin AIDS Behav Original Paper Differentiated service delivery and new products, such as long-acting injectable cabotegravir (CAB-LA) and the dapivirine vaginal ring (DVR), could increase uptake and use of pre-exposure prophylaxis (PrEP) for HIV prevention. We explored PrEP provider perspectives on differentiated PrEP service delivery and new PrEP products to inform World Health Organization (WHO) guidelines and programme implementation. 150 PrEP providers who participated in a WHO survey were randomly selected and 67 were invited for interviews based on geographic representation, provider cadre, gender, experience with community-based PrEP service delivery, and familiarity with new PrEP products. Semi-structured interviews were conducted virtually. Key themes were inductively extracted relating to differentiated service delivery and benefits and concerns regarding new PrEP products. 30 PrEP providers from 24 countries were interviewed. Across regions, providers were supportive of differentiated service delivery to respond to clients’ needs and preferences, maintain services during COVID-19, and ensure access for priority populations that may face access challenges. Providers welcomed prospects of offering CAB-LA to their clients but had concerns about HIV testing, costs, and the need for clinic-based services, including staff who can administer injections. Providers felt the DVR was potentially important for some cisgender women, especially young clients and female sex workers, and raised fewer concerns compared to injectable PrEP. Providers’ views are critical for the development of guidelines and implementing programmes that will best serve PrEP users. Understanding areas where provider capacities and biases may create barriers can define opportunities for training and support to ensure that providers can deliver effective programmes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10461-023-04093-1. Springer US 2023-06-23 2023 /pmc/articles/PMC10589125/ /pubmed/37351685 http://dx.doi.org/10.1007/s10461-023-04093-1 Text en © World Health Organization 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Paper
Henderson, Mary
Schmidt, Heather-Marie A
Chitembo, Lastone
Peralta, Hortencia
Alaama, Ahmed S
Johnson, Cheryl
Baggaley, Rachel
Schaefer, Robin
The Future of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention: A Global Qualitative Consultation on Provider Perspectives on New Products and Differentiated Service Delivery
title The Future of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention: A Global Qualitative Consultation on Provider Perspectives on New Products and Differentiated Service Delivery
title_full The Future of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention: A Global Qualitative Consultation on Provider Perspectives on New Products and Differentiated Service Delivery
title_fullStr The Future of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention: A Global Qualitative Consultation on Provider Perspectives on New Products and Differentiated Service Delivery
title_full_unstemmed The Future of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention: A Global Qualitative Consultation on Provider Perspectives on New Products and Differentiated Service Delivery
title_short The Future of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention: A Global Qualitative Consultation on Provider Perspectives on New Products and Differentiated Service Delivery
title_sort future of pre-exposure prophylaxis (prep) for hiv prevention: a global qualitative consultation on provider perspectives on new products and differentiated service delivery
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589125/
https://www.ncbi.nlm.nih.gov/pubmed/37351685
http://dx.doi.org/10.1007/s10461-023-04093-1
work_keys_str_mv AT hendersonmary thefutureofpreexposureprophylaxisprepforhivpreventionaglobalqualitativeconsultationonproviderperspectivesonnewproductsanddifferentiatedservicedelivery
AT schmidtheathermariea thefutureofpreexposureprophylaxisprepforhivpreventionaglobalqualitativeconsultationonproviderperspectivesonnewproductsanddifferentiatedservicedelivery
AT chitembolastone thefutureofpreexposureprophylaxisprepforhivpreventionaglobalqualitativeconsultationonproviderperspectivesonnewproductsanddifferentiatedservicedelivery
AT peraltahortencia thefutureofpreexposureprophylaxisprepforhivpreventionaglobalqualitativeconsultationonproviderperspectivesonnewproductsanddifferentiatedservicedelivery
AT alaamaahmeds thefutureofpreexposureprophylaxisprepforhivpreventionaglobalqualitativeconsultationonproviderperspectivesonnewproductsanddifferentiatedservicedelivery
AT johnsoncheryl thefutureofpreexposureprophylaxisprepforhivpreventionaglobalqualitativeconsultationonproviderperspectivesonnewproductsanddifferentiatedservicedelivery
AT baggaleyrachel thefutureofpreexposureprophylaxisprepforhivpreventionaglobalqualitativeconsultationonproviderperspectivesonnewproductsanddifferentiatedservicedelivery
AT schaeferrobin thefutureofpreexposureprophylaxisprepforhivpreventionaglobalqualitativeconsultationonproviderperspectivesonnewproductsanddifferentiatedservicedelivery
AT hendersonmary futureofpreexposureprophylaxisprepforhivpreventionaglobalqualitativeconsultationonproviderperspectivesonnewproductsanddifferentiatedservicedelivery
AT schmidtheathermariea futureofpreexposureprophylaxisprepforhivpreventionaglobalqualitativeconsultationonproviderperspectivesonnewproductsanddifferentiatedservicedelivery
AT chitembolastone futureofpreexposureprophylaxisprepforhivpreventionaglobalqualitativeconsultationonproviderperspectivesonnewproductsanddifferentiatedservicedelivery
AT peraltahortencia futureofpreexposureprophylaxisprepforhivpreventionaglobalqualitativeconsultationonproviderperspectivesonnewproductsanddifferentiatedservicedelivery
AT alaamaahmeds futureofpreexposureprophylaxisprepforhivpreventionaglobalqualitativeconsultationonproviderperspectivesonnewproductsanddifferentiatedservicedelivery
AT johnsoncheryl futureofpreexposureprophylaxisprepforhivpreventionaglobalqualitativeconsultationonproviderperspectivesonnewproductsanddifferentiatedservicedelivery
AT baggaleyrachel futureofpreexposureprophylaxisprepforhivpreventionaglobalqualitativeconsultationonproviderperspectivesonnewproductsanddifferentiatedservicedelivery
AT schaeferrobin futureofpreexposureprophylaxisprepforhivpreventionaglobalqualitativeconsultationonproviderperspectivesonnewproductsanddifferentiatedservicedelivery